Skip to content
A
  • HomeHome
  • SearchSearch
  • AskAsk
  • FollowingFollowing
  • SavedSaved

MedSIR

Organisation

Trials

  • NCT07460986

    Phase 1/2Recruiting2026278 people10 Mar 2026clinicaltrials.gov

  • NCT06382948

    Phase 3Recruiting2024300 people24 Apr 2024clinicaltrials.gov

  • NCT05659563

    Phase 2Completed202392 people21 Dec 2022clinicaltrials.gov

  • NCT05498896

    CollaboratorPhase 2Active, not recruiting2018146 people12 Aug 2022clinicaltrials.gov

  • NCT04300790

    Phase 2Completed202069 people9 Mar 2020clinicaltrials.gov

  • NCT03161353

    Phase 2Active, not recruiting2017377 people19 May 2017clinicaltrials.gov

© 2026 AgingResearch.News

PrivacyTermsContact

    News

    See all →

    Researchers link Jonathan’s longevity to limited genetic wear

    ResearchGEN and 2 more

    Longevica finds over sixty life-extending compounds in four-year mouse screen

    CompanyLongevity.Technology

    Immune aging accelerates near ages 40 and 60

    ResearchFuturity

    Trials

    See all →

    Registered6 Oct 2026

    AKG and Brain Health in Aging

    Phase 2 · University of Oklahoma

    Registered25 Sept 2026

    The Effect of Urolithin A (Mitopure®) on Alzheimer's Disease

    University Hospital, Akershus

    Registered2 Oct 2026

    Safety and Preliminary Efficacy of Adipose-Derived Stem Cell Secretome in Frailty (VinVital)

    Phase 1 · Vinmec Research Institute of Stem Cell and Gene Technology

    Trending

    Evidence →
    1. Intervention · 65 papersExercise
    2. Gene · 25 papersAPOE
    3. Disease · 122 papersCardiovascular disease
    4. Process · 127 papersInflammation
    5. Biomarker · 56 papersBody mass index
    6. Intervention · 40 papersSmoking

    Topics

    See all →
    • Mechanisms285
    • Interventions445
    • Biomarkers439
    • Populations564
    • AI & data174
    • Industry & policy22
    • Privacy
    • Terms
    • Contact
    • © 2026 AgingResearch.News